Influenza and pneumococcus vaccination rates in pediatric dialysis patients in Europe: recommendations vs reality A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group study

Influenza and pneumococcus vaccination rates in pediatric dialysis patients in Europe: recommendations vs reality A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group study

Background/aim: Children on dialysis are under increased risk of influenza and invasive pneumococcal disease. Although vaccination against these microorganisms are recommended in dialysis patients and despite the fact that these vaccines can reduce disease burden and rates of hospitalization due to infection, vaccination rates are below expected and desired. We aimed to evaluate influenza and pneumococcal vaccination and infection rates in European pediatric dialysis centers. Materials and methods: In 16 centers from 11 countries, 357 pediatric dialysis patients were evaluated retrospectively during 1 year of observation period between 01.01.2014 and 01.01.2015. Results: In all centers, vaccination policy included immunization of dialysis patients with inactive influenza vaccine and pneumococcal conjugate vaccine (PCV). Fifty percent of the centers recommended pneumococcal polysaccharide vaccine following routine PCV series. A significantly higher pneumococcal vaccination rate (43.9%) was seen in peritoneal dialysis (PD) patients compared to those on hemodialysis (HD) (32.9%) (p = 0.035), while the rates for influenza were similar (42.4% and 46.1% respectively, p = 0.496). Among all dialysis patients, 2.2% (n = 8) developed pneumonia and 6.4% (n = 23) was infected by Influenza. Pneumococcic pneumonia rate was 5% for 140 patients who received antipneumococcal vaccine, while only one pneumonia episode was recorded out of 217 unvaccinated patients (p = 0.007). The influenza virus infection rates were similar for patients vaccinated and nonvaccinated (7 % and 6 %, respectively). Conclusions: Although influenza and pneumococcal vaccines are highly recommended in pediatric dialysis patients, vaccination rates were lower than expected. Pneumococcal vaccination rates were higher in PD compared to the patients on HD. The rate of children with influenza infection was higher than pneumonia. The efficacy of influenza and pneumococcal vaccines was highlighted by the low infection rates. Higher pneumonia rates in patients vaccinated against pneumococcus compared to unvaccinated ones might be due to coexisting risk factors.Key words: Dialysis, immunization, influenza vaccine, pneumococcal vaccine, vaccination

___

  • 1. Esposito S, Mastrolia MV, Prada E, Pietrasanta C, Principi N. Vaccine administration in children with chronic kidney disease. Vaccine 2014 20; 32(49): 6601-6606. doi: 10.1016/j.vaccine.2014.09.038
  • 2. Neu AM. Immunizations in children with chronic kidney disease. Pediatric Nephrology 2012; 27(8): 1257-1263. doi: 10.1007/s00467-011-2042-3
  • 3. Neuhaus TJ. Immunization in children with chronic renal failure: a practical approach. Pediatric Nephrology 2004; 19(12): 1334-1339. doi: 10.1007/s00467-004-1597-7
  • 4. Laube GF, Berger C, Goetschel P, Leumann E, Neuhaus TJ. Immunization in children with chronic renal failure. Pediatric Nephrology 2002; 17(8): 638-642. doi: 10.1007/s00467-002- 0869-3
  • 5. Hjuler T, Wohlfahrt J, Staum Kaltoft M, Koch A, Biggar RJ et al. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics 2008; 122(1): e 26-32. doi: 10.1542/peds.2007-1510
  • 6. Vandecasteele SJ, Ombelet S, Blumental S, Peetermans WE. The ABC of pneumococcal infections and vaccination in patients with chronic kidney disease. Clinical Kidney Journal 2015; 8(3): 318-324. doi: 10.1093/ckj/sfv030
  • 7. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R et al. Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clinical Infectious Diseases 2014 Feb; 58(3): 309-18. doi: 10.1093/cid/cit816. Erratum in: Clinical Infectious Diseases 2014 Jul 1; 59(1): 144.
  • 8. Mastalerz-Migas A, Gwiazda E, Brydak LB. Effectiveness of influenza vaccine in patients on hemodialysis—a review. Medical Science Monitor 2013; 19: 1013-1018. Published 2013 Nov 18. doi: 10.12659/MSM.889671
  • 9. Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infectious Diseases 2009; 9(8): 493-504. doi: 10.1016/S1473-3099(09)70175-6
  • 10. Gilbertson DT, Unruh M, McBean AM, Kausz AT, Snyder JJ et al. Influenza vaccine delivery and effectiveness in end stage renal disease. Kidney International 2003; 63(2): 738-743. doi: 10.1046/j.1523-1755.2003.00787.x
  • 11. Grzegorzewska AE. Prophylactic vaccinations in chronic kidney disease: Current status. Human Vaccines &Immunotherapeutics 2015; 11(11): 2599-2605. doi: 10.1080/21645515.2015.1034915
  • 12. Centers for Disease Control and Prevention (CDC): Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices–United States, 2013–2014. MMWR Recommendations and Reports 2013; 62 (RR07): 1-43
  • 13. National Advisory Committee on Immunization (NACI): Statement on Seasonal Influenza Vaccine for 2013–2014. Canada Communicable Disease Report. October 2013, Volume 39, ACS-4; doi: 10.14745/ccdr. v39i00a04
  • 14. U.S. Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010
  • 15. U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013
  • 16. Chaves TSS, Pereira LM, De Santos SS, David-Neto E, Lopes MH. Evaluation of the vaccination status in pediatric renal transplant recipients. Pediatric Transplantation 2008; 12(4): 432-435. doi: 10.1111/j.1399-3046.2007.00820.x
  • 17. Höcker B, Aguilar M, Schnitzler P, Pape L, Dello Strologo L et al. Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation. Pediatric Nephrology 2018; 33(2): 341-350. doi: 10.1007/s00467-017-3776-3
  • 18. Bitsori M, Galanakis E. Vaccine-preventable infection morbidity of patients with chronic kidney disease and cocoon vaccination strategies. Expert Review of Vaccines. 2015; 14(10): 1385-1395. doi: 10.1586/14760584.2015.1075397
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Investigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate

Aysun AYBAL KUTLUGÜN, Esin BEYAN, Betül ERGÜN, Mustafa Çağrı ERGÜN, Galip AKTÜRK

Distal spread and tumor regression patterns following preoperative chemoradiotherapy in rectal cancer patients

Erdal Birol BOSTANCI, Hacı Murat ÇAYCI, Tahsin DALGIÇ, İlter ÖZER, Neslihan İnci ZENGİN, Adem YÜKSEL, Murat ULAŞ, Musa AKOĞLU

Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer

Asena GÖKÇAY CANPOLAT, Demet ÇORAPÇIOĞLU, Mustafa ŞAHİN, Özgür DEMİR, Koray CEYHAN, Rıfat EMRAL, Murat Faik ERDOĞAN, Sevim GÜLLÜ, Serpil SAK

Maintenance of pulmonary rehabilitation benefits in patients with COPD: is a structured 5-year follow-up program helpful?

İpek CANDEMIR, Pınar ERGÜN, Mustafa Engin ŞAHİN

Protective effects of anandamide against cisplatin-induced peripheral neuropathy in rats

Çiğdem ÇENGELLİ ÜNEL, Başak AYAZ, Kevser EROL, Emel ULUPINAR, Şule AYDIN, Bilgin KAYGISIZ, Engin YILDIRIM, Orhan ÖZATİK

Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic

Güldane CENGİZ SEVA, Pervin TOPÇUOĞLU, Taner DEMİRER

Prognostic factors for 30-days mortality in eighty years aged and older critically ill patients: a single center retrospective cohort study

Umut Sabri KASAPOĞLU, Osman KAÇMAZ, Abdullah GÖK, Merih YILDIZ EGLEN, Hasan ŞAYAN, Fatih ÇOLAK

Correlation of neuroimaging and thorax CT findings in patients with COVID-19: A large single-center experience

Hediye Pınar GÜNBEY, Ayşe BATIREL, Günay RONA, Özge ADIGÜZEL KARAOYSAL, Banu ÖZEN BARUT

Decrease of left ventricular ejection fraction in severe illness patients due to COVID-19 may improve as the disease resolves

Mustafa DOĞAN, Lütfi Çağatay ONAR, Aykut DEMİRKIRAN

Clinicopathological features of mammary Paget’s disease: a single-center experience in Turkey

Mustafa Agah TEKİNDAL, Özlem GÜR, Seyran YİĞİT, Demet ETİT, Kemal ATAHAN, Nihan ACAR, Sultan Deniz ALTINDAĞ2, Haldun KAR, Betül KÜÇÜKZEYBEK, Özgün AKGÜL